Selected cases demonstrating the value of furosemide-primed 18F-FDG PET in identifying adrenal involvement

Journal of Nuclear Medicine Technology

Volumn 33, Issue 3, 2005, Pages 166-171

  Nair, Narendra ^a   Basu, Sandip ^a,b  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

18F FDG PET; Adrenal metastasis; Furosemide

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FUROSEMIDE; TRACER; DIAGNOSTIC AGENT; DIURETIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADRENAL METASTASIS; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HUMAN; LYMPHADENOPATHY; ADENOCARCINOMA; ADOLESCENT; ADRENAL TUMOR; CASE REPORT; FEMALE; INFANT; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; SCINTISCANNING;

ADENOCARCINOMA; ADOLESCENT; ADRENAL GLAND NEOPLASMS; CHILD, PRESCHOOL; DIURETICS; FEMALE; FLUORODEOXYGLUCOSE F18; FUROSEMIDE; HUMANS; INFANT; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 33644694907     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Miraldi F, Vesselle H, Faulhaber PF, Adler LP, Leisure GP. Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer. Clin Nucl Med. 1998;23:3-7.
2. Vesselle HJ, Miraldi FD. FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls. Radiographics. 1998;18:805-824.
3. Liu IJ, Zafar MB, Lai YH, Segall GM, Terris MK. Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology. 2001;57:108-111.
4. Leisure GP, Vesselle HJ, Faulhaber PF, O'Donnell JK, Adler LP, Miraldi F. Technical improvements in fluorine-18-FDG PET imaging of the abdomen and pelvis. J Nucl Med Technol. 1997;25:115-119.
5. 18F]fluoro-D-glucose (FDG) activity in the urinary system. Ann Nucl Med. 1997;11:213-218.